Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Delphine Hequet 2017. Prospective study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-ProsignaTM Test (Assay) in the management of early-stage breast cancers.. protocols.io dx.doi.org/10.17504/protocols.io.jrucm6wCopy Citation Copied
URL: https://dx.doi.org/10.17504/protocols.io.jrucm6w
Authors: Delphine Hequet
Summary: Please see attached protocol
Associated Publications: Hequet D, Callens C, Gentien D, Albaud B, Mouret-Reynier M, Dubot C, Cottu P, Huchon C, Zilberman S, Berseneff H, Foa C, Salmon R, Roulot A, Lerebours F, Salomon A, Ghali N, Morel P, Li Q, Cayre A, Guinebretière J, Hornberger J, Penault-Llorca F, Rouzier R (2017) Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers. PLoS ONE 12(10): e0185753. doi: 10.1371/journal.pone.0185753
Affiliations: Institut C
External URL: https://doi.org/10.1371/journal.pone.0185753
Version: 1
Publication Date: 2017
Expand AllComing soon.
Source: Protocols.io